Tag : biopharmaceutical company

Healthcare Quality, Patient Safety & Policy

Boehringer Ingelheim, Cue Biopharma Partner on Autoimmune Therapies

GlobeNewswire
by GlobeNewswire04
Boehringer Ingelheim and Cue Biopharma, Inc. (Nasdaq: CUE) today announced a strategic research collaboration and license agreement to develop and commercialize Cue Biopharma’s CUE-501 product candidate, a...
Clinical Research, Pharma & Healthcare Financing

Oculis Hosts R&D Event to Share Pipeline Progress Today

GlobeNewswire
by GlobeNewswire05
Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with...
Clinical Research, Pharma & Healthcare Financing

Savara Secures Up to $200M Non-Dilutive Debt Financing

Business Wire
by Business Wire025
Includes $30M at Close to Refinance Existing Debt Facility Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today...
Clinical Research, Pharma & Healthcare Financing

Celltrion’s Remdantry™ to launch in Canada on April 1, 2025

Business Wire
by Business Wire017
Celltrion, Inc., a leading global biopharmaceutical company, announced that Remdantry™ will be available in Canada as of April 1, 2025. Remdantry™, previously known as Inflectra®,...
Clinical Research, Pharma & Healthcare Financing

RedHill Biopharma to Submit Talicia® for UK Approval

PR Newswire
by PR Newswire025
RedHill plans to submit UK MAA1 for Talicia for H. pylori infection, using MHRA’s2 new fast-track approval process, referencing FDA approval, with potential UK approval in Q4/25 Listed...
Workforce Development & Leadership

iOncologi Appoints Dr. Mona Flores and Mr. Paolo Fundarò to Board

PR Newswire
by PR Newswire018
iOncologi, Inc. (www.ioncologi.com), a clinical-stage biopharmaceutical company pioneering novel immunotherapies for cancer treatment, today announced the appointment of Dr. Mona Flores and Mr. Paolo Fundarò to its...
Copyright © 2025 BI-Journal. All Rights Reserved. Privacy Policy